search
Back to results

A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis

Primary Purpose

Moderate to Severe Chronic Plaque Psoriasis

Status
Recruiting
Phase
Phase 3
Locations
China
Study Type
Interventional
Intervention
JS005 (recombinant humanized monoclonal antibody against IL-17A)
Sponsored by
Shanghai Junshi Bioscience Co., Ltd.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Moderate to Severe Chronic Plaque Psoriasis

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Subjects voluntarily particpate in this clinical study and sign the informed consent form. Male and female patients aged 18-75 years at the time of screening (both inclusive). Fertile female subjects must be willing to use a highly effective contraceptive method during the study period and 20 weeks (expected 5 half-lives) after the last study drug administration and have a negative pregnancy test during the screening period and prior to randomization. Exclusion Criteria: Pregnant and lactating women. A history of inflammatory bowel disease or other conditions with a high risk of perforation (e.g., severe gastrointestinal ulcers, etc.) or with other active autoimmune diseases (e.g., systemic lupus erythematosus, Sarcoidosis, etc.). Have a type of psoriasis other than chronic plaque psoriasis (e.g., pustular, erythrodermic, and guttate psoriasis), drug-induced psoriasis, or have an active inflammatory skin disease other than psoriasis Use of phototherapy, including but not limited to ultraviolet A phototherapy (with or without psoralens), ultraviolet B phototherapy, or excimer laser within 4 weeks prior to randomization. Subjects are unwilling to avoid excessive sunlight exposure within 4 weeks prior to randomization and during the study period; A (current) history of systemic infection or serious infection requiring hospitalization and/or intravenous anti-infective therapy (e.g., antibiotics, antifungal agents, antiviral agents) within 12 weeks prior to randomization; a history of any active infection, other than common upper respiratory infections, within 2 weeks prior to randomization;

Sites / Locations

  • The First Affiliated Hospital of Bengbu Medical College
  • The Second Affiliated Hospital of Anhui Medical University
  • Beijing Friendship Hospital, Capital Medical University
  • Beijing Tongren Hospital Affiliated to Capital Medical University
  • China-Japan Friendship Hospital
  • Peking University People's Hospital
  • Peking University Third Hospital
  • Ningbo Huamei Hospital, University of Chinese Academy of Sciences
  • The First Affiliated Hospital of Chongqing Medical University
  • The First Affiliated Hospital of Fujian Medical University
  • The Second Affiliated Hospital of Xiamen Medical College
  • Lanzhou University Second Hospital
  • Dongguan People's Hospital
  • Guangdong General Hospital
  • Dermatology Hospital of Southern Medical University
  • Guangzhou First People's Hospital
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University
  • Shenzhen People's Hospital
  • The Affiliated Hospital of Chengde Medical College
  • The First Hospital of Hebei Medical University
  • Xingtai People's Hospital
  • Nanyang city first People's Hospital
  • The First Affiliated Hospital of Xinxiang Medical College
  • Jingzhou Central Hospital
  • Shiyan City People's Hospital
  • Wuhan University People's Hospital
  • The Second Xiangya Hospital, Central South University
  • Xiangya Third Hospital, Central South University
  • Lianyungang First People's Hospital
  • The First Affiliated Hospital of Soochow University
  • Wuxi Second People's Hospital
  • Yancheng First People's Hospital
  • Affiliated Hospital of Jiangsu University
  • The First Affiliated Hospital of Gannan Medical College
  • Jiangxi Dermatology HospitalRecruiting
  • The Second Affiliated Hospital of Nanchang University
  • Bethune First Hospital of Jilin University
  • Panjin Liao oil precious stone flower hospital
  • Shengjing Hospital affiliated to China Medical University
  • Shenyang Hospital of Integrated Chinese and Western Medicine
  • North East Central International Hospital Limited
  • Baotou Central Hospital
  • Inner Mongolia Baotou Steel Hospital
  • Ningxia Medical University General Hospital
  • Shandong Dermatology Hospital
  • Jinan Central Hospital
  • Shanghai Dermatology Hospital
  • The Second Hospital of Shanxi Medical University City:Taiyuan
  • The First Affiliated Hospital of Xi 'an Jiaotong University City:Xian
  • Medicine School of Xi'an Jiaotong University
  • Chengdu Second People's Hospital
  • West China Hospital of Sichuan University
  • Suining Central Hospital
  • Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
  • The Second Affiliated Hospital of Kunming Medical University
  • Hangzhou Third People's Hospital
  • Hangzhou First People's Hospital
  • Zhejiang Provincial People's Hospital
  • Run Run Shaw Hospital, Zhejiang University School of Medicine
  • The First Hospital of Jiaxing
  • The First Affiliated Hospital of Wenzhou Medical University

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Placebo Comparator

Arm Label

JS005 150mg (recombinant humanized monoclonal antibody against IL-17A)

JS005 300mg (recombinant humanized monoclonal antibody against IL-17A)

Placebo

Arm Description

Outcomes

Primary Outcome Measures

Change in PASI 90
The proportion of patients who achieved at least 90% improvement from baseline in psoriasis area and severity index (PASI 90) at week 12
Change in sPGA
The proportion of patients who achieved a static physician Comprehensive Assessment (sPGA) score of 0 or 1 at week 12.

Secondary Outcome Measures

Patients achieving PASI 75 at Week 12
The proportion of patients who achieved at least 75% improvement from baseline in psoriasis area and severity index (PASI 90) at week 12
Patients achieving PASI 100 at Week 12
The proportion of patients who achieved at least 100% improvement from baseline in psoriasis area and severity index (PASI 90) at week 12
Proportion of subjects with a sPGA score of 0 at week 12
The proportion of patients who achieved at least 0 at week 12
Proportion of subjects with a DLQI score of 0/1 at week 12
The proportion of patients who with a DLQI score at least 0/1 at week 12
Patients achieving PASI 75 at Week 52
Proportion of participants with a PASI score improvement of at least 75% (PASI 75) from baseline at week 52
Time to PASI 75/90 response
Time to PASI 75/90 response within 12 weeks
Time to sPGA 0/1 response
Time to sPGA 0/1 response within 12 weeks
Patients achieving PASI 90 at Week 52
Proportion of participants with a PASI score improvement of at least 90 (PASI 90) from baseline at week 52
Patients achieving PASI 100 at Week 52
Proportion of participants with a PASI score improvement of at least 100 from baseline (PASI 100) at week 52

Full Information

First Posted
July 27, 2023
Last Updated
September 13, 2023
Sponsor
Shanghai Junshi Bioscience Co., Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT05975268
Brief Title
A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis
Official Title
A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 28, 2023 (Actual)
Primary Completion Date
May 31, 2024 (Anticipated)
Study Completion Date
October 10, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Shanghai Junshi Bioscience Co., Ltd.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase III clinical study to evaluate the efficacy and safety of JS005 in 702 adult patients with moderate-to-severe chronic plaque psoriasis
Detailed Description
The study consisted of four periods: screening period (up to 4 weeks), induction period (12 weeks), maintenance period (40 weeks) and follow-up period (8 weeks). This study planned to recruit 702 subjects, who were randomized into JS005 300mg group (234 subjects), JS005 150mg group (234 subjects) and placebo group (234 subjects) at a ratio of 1:1:1, and were stratified by whether they had previsouly received biologic treatments (continuous biologic treatment for ≥3 months at recommended doses or intolerance for safety reasons) and body weight (≥70 kg or < 70 kg).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Moderate to Severe Chronic Plaque Psoriasis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Model Description
Parallel
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
The study uses a double-blind design in which subjects, investigators, and other researchers will remain blind to the allocation of the study drug and placebo. If serious adverse events occur to subjects during the study, the investigator must be informed of the treatment received by the subjects before appropriate treatment can be given. For safety reasons, the investigator may unblind the subjects urgently after obtaining the consent of the sponsor's medical monitor.
Allocation
Randomized
Enrollment
702 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
JS005 150mg (recombinant humanized monoclonal antibody against IL-17A)
Arm Type
Experimental
Arm Title
JS005 300mg (recombinant humanized monoclonal antibody against IL-17A)
Arm Type
Experimental
Arm Title
Placebo
Arm Type
Placebo Comparator
Intervention Type
Biological
Intervention Name(s)
JS005 (recombinant humanized monoclonal antibody against IL-17A)
Intervention Description
JS005/placebo
Primary Outcome Measure Information:
Title
Change in PASI 90
Description
The proportion of patients who achieved at least 90% improvement from baseline in psoriasis area and severity index (PASI 90) at week 12
Time Frame
From week 0 to week 12
Title
Change in sPGA
Description
The proportion of patients who achieved a static physician Comprehensive Assessment (sPGA) score of 0 or 1 at week 12.
Time Frame
From week 0 to week 12
Secondary Outcome Measure Information:
Title
Patients achieving PASI 75 at Week 12
Description
The proportion of patients who achieved at least 75% improvement from baseline in psoriasis area and severity index (PASI 90) at week 12
Time Frame
From week 0 to week 12
Title
Patients achieving PASI 100 at Week 12
Description
The proportion of patients who achieved at least 100% improvement from baseline in psoriasis area and severity index (PASI 90) at week 12
Time Frame
From week 0 to week 12
Title
Proportion of subjects with a sPGA score of 0 at week 12
Description
The proportion of patients who achieved at least 0 at week 12
Time Frame
From week 0 to week 12
Title
Proportion of subjects with a DLQI score of 0/1 at week 12
Description
The proportion of patients who with a DLQI score at least 0/1 at week 12
Time Frame
From week 0 to week 12
Title
Patients achieving PASI 75 at Week 52
Description
Proportion of participants with a PASI score improvement of at least 75% (PASI 75) from baseline at week 52
Time Frame
From week 0 to week 52
Title
Time to PASI 75/90 response
Description
Time to PASI 75/90 response within 12 weeks
Time Frame
From week 0 to week 12
Title
Time to sPGA 0/1 response
Description
Time to sPGA 0/1 response within 12 weeks
Time Frame
From week 0 to week 12
Title
Patients achieving PASI 90 at Week 52
Description
Proportion of participants with a PASI score improvement of at least 90 (PASI 90) from baseline at week 52
Time Frame
From week 0 to week 52
Title
Patients achieving PASI 100 at Week 52
Description
Proportion of participants with a PASI score improvement of at least 100 from baseline (PASI 100) at week 52
Time Frame
From week 0 to week 52

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subjects voluntarily particpate in this clinical study and sign the informed consent form. Male and female patients aged 18-75 years at the time of screening (both inclusive). Fertile female subjects must be willing to use a highly effective contraceptive method during the study period and 20 weeks (expected 5 half-lives) after the last study drug administration and have a negative pregnancy test during the screening period and prior to randomization. Exclusion Criteria: Pregnant and lactating women. A history of inflammatory bowel disease or other conditions with a high risk of perforation (e.g., severe gastrointestinal ulcers, etc.) or with other active autoimmune diseases (e.g., systemic lupus erythematosus, Sarcoidosis, etc.). Have a type of psoriasis other than chronic plaque psoriasis (e.g., pustular, erythrodermic, and guttate psoriasis), drug-induced psoriasis, or have an active inflammatory skin disease other than psoriasis Use of phototherapy, including but not limited to ultraviolet A phototherapy (with or without psoralens), ultraviolet B phototherapy, or excimer laser within 4 weeks prior to randomization. Subjects are unwilling to avoid excessive sunlight exposure within 4 weeks prior to randomization and during the study period; A (current) history of systemic infection or serious infection requiring hospitalization and/or intravenous anti-infective therapy (e.g., antibiotics, antifungal agents, antiviral agents) within 12 weeks prior to randomization; a history of any active infection, other than common upper respiratory infections, within 2 weeks prior to randomization;
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jianzhong Zhang, M.D.
Phone
8618001315877
Email
Rmzjz@126.com
Facility Information:
Facility Name
The First Affiliated Hospital of Bengbu Medical College
City
Bengbu
State/Province
Anhui
ZIP/Postal Code
233004
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hongfang Han, M.D.
Phone
8613865019127
Email
627075942@qq.com
Facility Name
The Second Affiliated Hospital of Anhui Medical University
City
Hefei
State/Province
Anhui
ZIP/Postal Code
230601
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chunjun Yang, M.D.
Phone
8613966681316
Email
aydefyllwyhbgs@163.com
Facility Name
Beijing Friendship Hospital, Capital Medical University
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100044
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lingfeng Li, M.D.
Phone
8613693620186
Email
zoonli@sina.com
Facility Name
Beijing Tongren Hospital Affiliated to Capital Medical University
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100044
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Aihua Wei, M.D.
Phone
8615810585889
Email
weiaihua3000@163.com
Facility Name
China-Japan Friendship Hospital
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100044
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yong Cui, M.D.
Phone
8617150070682
Email
wuhucuiyong@vip.163.com
Facility Name
Peking University People's Hospital
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100044
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jianzhong Zhang, M.D.
Phone
+8618001315877
Email
Rmzjz@126.com
Facility Name
Peking University Third Hospital
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100044
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Wenhui Wang, M.D.
Phone
8618618269437
Email
wwh0608@126.com
Facility Name
Ningbo Huamei Hospital, University of Chinese Academy of Sciences
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100864
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jinyan Wang, M.D.
Phone
8613586795265
Email
rypamy@163.com
Facility Name
The First Affiliated Hospital of Chongqing Medical University
City
Chongqing
State/Province
Chongqing
ZIP/Postal Code
400016
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Aijun Chen, M.D.
Phone
8613062377863
Email
1360999716@qq.com
Facility Name
The First Affiliated Hospital of Fujian Medical University
City
Fuzhou
State/Province
Fujian
ZIP/Postal Code
350005
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chao Ji, M.D.
Phone
8618651619908
Email
surpassing_ji@163.com
Facility Name
The Second Affiliated Hospital of Xiamen Medical College
City
Xiamen
State/Province
Fujian
ZIP/Postal Code
361023
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mingkai Ji, M.D.
Phone
8613075959049
Email
Mingkai_ji@163.com
Facility Name
Lanzhou University Second Hospital
City
Lanzhou
State/Province
Gansu
ZIP/Postal Code
730030
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Taoxiang Niu, M.D.
Phone
8615193189096
Email
niutx@163.com
Facility Name
Dongguan People's Hospital
City
Dongguan
State/Province
Guangdong
ZIP/Postal Code
523018
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Guangming Han, M.D.
Phone
8613533391069
Email
Ghan54321@163.com
Facility Name
Guangdong General Hospital
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510080
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zhu Shen, M.D.
Phone
8613983174426
Email
zhshencq@163.com
Facility Name
Dermatology Hospital of Southern Medical University
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510091
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xiaohua Wang, M.D.
Phone
8613763359607
Email
wxh-21773@163.com
Facility Name
Guangzhou First People's Hospital
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510180
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jiang Wu, M.D.
Phone
8618922182868
Email
wj642@163.com
Facility Name
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
518107
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Qing Guo, M.D.
Phone
8618922182868
Email
guoqingzsy@163.com
Facility Name
Shenzhen People's Hospital
City
Shenzhen
State/Province
Guangdong
ZIP/Postal Code
518020
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jianglin Zhang, M.D.
Phone
8613873143466
Email
zhang.jianglin@szhospital.com
Facility Name
The Affiliated Hospital of Chengde Medical College
City
Chengde
State/Province
Hebei
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xisuo Duan, M.D.
Phone
8615633142680
Email
15633142680@163.com
Facility Name
The First Hospital of Hebei Medical University
City
Shijiazhuang
State/Province
Hebei
ZIP/Postal Code
050000
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Guoqiang Zhang, M.D.
Phone
8618633888122
Email
zgq810328@sina.com
Facility Name
Xingtai People's Hospital
City
Xingtai
State/Province
Hebei
ZIP/Postal Code
054031
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fang Cheng, M.D.
Phone
8618931912286
Email
18931912286@163.com
Facility Name
Nanyang city first People's Hospital
City
Nanyang
State/Province
Henan
ZIP/Postal Code
473000
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rixin Chen, M.D.
Phone
8613849795170
Email
pfkgcpby@163.com
Facility Name
The First Affiliated Hospital of Xinxiang Medical College
City
Xinxiang
State/Province
Henan
ZIP/Postal Code
453100
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zhongwei Tian, M.D.
Phone
8615637358828
Email
zhonwt@xxmu.edu.cn
Facility Name
Jingzhou Central Hospital
City
Jingzhou
State/Province
Hubei
ZIP/Postal Code
434020
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tongxiang Zeng, M.D.
Phone
8613339737387
Email
331867948@qq.com
Facility Name
Shiyan City People's Hospital
City
Shiyan
State/Province
Hubei
ZIP/Postal Code
442000
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zudong Meng, M.D.
Phone
8613997837543
Email
1970547910@qq.com
Facility Name
Wuhan University People's Hospital
City
Wuhan
State/Province
Hubei
ZIP/Postal Code
430060
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tiechi Lei, M.D.
Phone
8615337173507
Email
tiechilei@126.com
Facility Name
The Second Xiangya Hospital, Central South University
City
Changsha
State/Province
Hunan
ZIP/Postal Code
410008
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rong Xiao, M.D.
Phone
8613808425555
Email
xiaorong65@aliyun.com
Facility Name
Xiangya Third Hospital, Central South University
City
Changsha
State/Province
Hunan
ZIP/Postal Code
410013
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jianyun Lu, M.D.
Phone
8613975130008
Email
1010739024@qq.com
Facility Name
Lianyungang First People's Hospital
City
Lianyungang
State/Province
Jiangsu
ZIP/Postal Code
222002
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hong Ren, M.D.
Phone
8618961326020
Email
irb_lygyyy@163.com
Facility Name
The First Affiliated Hospital of Soochow University
City
Suzhou
State/Province
Jiangsu
ZIP/Postal Code
215123
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jisheng Liu, M.D.
Phone
8613913719333
Email
yzl6405@163.com
Facility Name
Wuxi Second People's Hospital
City
Wuxi
State/Province
Jiangsu
ZIP/Postal Code
214002
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xiaohong Zhu, M.D.
Phone
8613395172837
Email
zxh6801@126.com
Facility Name
Yancheng First People's Hospital
City
Yancheng
State/Province
Jiangsu
ZIP/Postal Code
224006
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pingping Qin, M.D.
Phone
8613601413122
Email
ycyylwh@163.com
Facility Name
Affiliated Hospital of Jiangsu University
City
Zhenjiang
State/Province
Jiangsu
ZIP/Postal Code
212000
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yumei Li, M.D.
Phone
8613914569541
Email
yumei@aliyun.com
Facility Name
The First Affiliated Hospital of Gannan Medical College
City
Ganzhou
State/Province
Jiangxi
ZIP/Postal Code
341000
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jingfa Lu, M.D.
Phone
8613479725817
Email
lujingfa@126.com
Facility Name
Jiangxi Dermatology Hospital
City
Nanchang
State/Province
Jiangxi
ZIP/Postal Code
330000
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fengming Hu, M.D.
Phone
8618907802429
Email
1262200957@qq.com
Facility Name
The Second Affiliated Hospital of Nanchang University
City
Nanchang
State/Province
Jiangxi
ZIP/Postal Code
330006
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Meiying Jiang, M.D.
Phone
8613870913263
Email
151465672@qq.com
Facility Name
Bethune First Hospital of Jilin University
City
Changchun
State/Province
Jilin
ZIP/Postal Code
130021
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shanshan Li, M.D
Phone
8613756661632
Email
shansalee@163.com
Facility Name
Panjin Liao oil precious stone flower hospital
City
Panjin
State/Province
Liaoning
ZIP/Postal Code
124011
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yingxia He, M.D.
Phone
8613904273211
Email
1462619572@qq.com
Facility Name
Shengjing Hospital affiliated to China Medical University
City
Shenyang
State/Province
Liaoning
ZIP/Postal Code
110004
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xiuping Han, M.D.
Phone
8618940251646
Email
hanxiuping66@126.com
Facility Name
Shenyang Hospital of Integrated Chinese and Western Medicine
City
Shenyang
State/Province
Liaoning
ZIP/Postal Code
110021
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xiaodong Sun, M.D.
Phone
8613591454517
Email
gemmapeter@163.com
Facility Name
North East Central International Hospital Limited
City
Shenyang
State/Province
Liaoning
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shifa Zhang, M.D.
Phone
8613190010100
Email
zhangshifa_1963@126.com
Facility Name
Baotou Central Hospital
City
Baotou
State/Province
Neimenggu
ZIP/Postal Code
014040
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Guohui Zhang, M.D.
Phone
13734809158
Email
1259314465@qq.com
Facility Name
Inner Mongolia Baotou Steel Hospital
City
Baotou
State/Province
Neimengu
ZIP/Postal Code
010000
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Min Zhang, M.D.
Phone
8613847245128
Email
nmgzm@126.com
Facility Name
Ningxia Medical University General Hospital
City
Yinchuan
State/Province
Ningxia
ZIP/Postal Code
750004
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nan Yu, M.D.
Phone
8613895095009
Email
13895095009@163.com
Facility Name
Shandong Dermatology Hospital
City
Jinan
State/Province
Shandong
ZIP/Postal Code
250000
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Furen Zhang, M.D.
Phone
8613608921718
Email
zhangfuren@hotmail.com
Facility Name
Jinan Central Hospital
City
Jinan
State/Province
Shandong
ZIP/Postal Code
250013
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lihua Wang, M.D.
Phone
8615318816237
Email
15318816237@163.com
Facility Name
Shanghai Dermatology Hospital
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
200050
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yangfeng Ding, M.D.
Phone
8618017336636
Email
dingyangfeng@aliyun.com
Facility Name
The Second Hospital of Shanxi Medical University City:Taiyuan
City
Taiyuan
State/Province
Shanxi
ZIP/Postal Code
030001
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Wenli Feng, M.D.
Phone
8613935198008
Email
fwl92@hotmail.com
Facility Name
The First Affiliated Hospital of Xi 'an Jiaotong University City:Xian
City
Xi'an
State/Province
Shanxi
ZIP/Postal Code
710061
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Miao Zheng, M.D.
Phone
8615319931238
Email
zenyan66@126.com
Facility Name
Medicine School of Xi'an Jiaotong University
City
Xian
State/Province
Shanxi
ZIP/Postal Code
710004
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Songmei Geng, M.D.
Phone
8613060423612
Email
gsm312@yahoo.com
Facility Name
Chengdu Second People's Hospital
City
Chengdu
State/Province
Sichuan
ZIP/Postal Code
610017
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yanyan Feng, M.D.
Phone
8619150169967
Email
fyymed@163.com
Facility Name
West China Hospital of Sichuan University
City
Chengdu
State/Province
Sichuan
ZIP/Postal Code
610041
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Wei Li, M.D.
Phone
8618980601695
Email
724564806@qq.com
Facility Name
Suining Central Hospital
City
Suining
State/Province
Sichuan
ZIP/Postal Code
629000
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chunshui Yu, M.D.
Phone
8618008256917
Email
373405810@qq.com
Facility Name
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
City
Tianjin
State/Province
Tianjin
ZIP/Postal Code
300120
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Litao Zhang, M.D.
Phone
8618602228122
Email
zhanglitao@medmail.com.cn
Facility Name
The Second Affiliated Hospital of Kunming Medical University
City
Kunming
State/Province
Yunnan
ZIP/Postal Code
650118
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yunhui Yang, M.D.
Phone
8613888139863
Email
danqid128@sina.com
Facility Name
Hangzhou Third People's Hospital
City
Hangzhou
State/Province
Zhejiang
ZIP/Postal Code
310002
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tianhong Xu, M.D.
Phone
8613282842619
Email
1467314735@qq.com
Facility Name
Hangzhou First People's Hospital
City
Hangzhou
State/Province
Zhejiang
ZIP/Postal Code
310006
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Liming Wu, M.D.
Phone
8613750837205
Email
18957118053@163.com
Facility Name
Zhejiang Provincial People's Hospital
City
Hangzhou
State/Province
Zhejiang
ZIP/Postal Code
310014
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xiaohua Tao, M.D.
Phone
8613505811700
Email
13505811700@163.com
Facility Name
Run Run Shaw Hospital, Zhejiang University School of Medicine
City
Hangzhou
State/Province
Zhejiang
ZIP/Postal Code
310016
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hao Cheng, M.D.
Phone
8613588706943
Email
xumingsrrsh@foxmail.com
Facility Name
The First Hospital of Jiaxing
City
Jiaxing
State/Province
Zhejiang
ZIP/Postal Code
314001
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Wenhao Yin, M.D.
Phone
8613957322306
Email
whyin69@sina.com
Facility Name
The First Affiliated Hospital of Wenzhou Medical University
City
Wenzhou
State/Province
Zhejiang
ZIP/Postal Code
325000
Country
China
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zhiming Li, M.D.
Phone
8615988718867
Email
wyyyll01@163.com

12. IPD Sharing Statement

Learn more about this trial

A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis

We'll reach out to this number within 24 hrs